The natural history of conditional transcranial Doppler flow velocities in children with sickle cell anaemia

Jane S. Hankins, Gail L. Fortner, M. Beth McCarville, Matthew P. Smeltzer, Winfred C. Wang, Chin-Shang Li, Russell E. Ware

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Children with sickle cell anaemia (SCA) and conditional transcranial Doppler (TCD) [time-averaged mean velocity (TAMV) 170-199 cm/s] have increased risk of primary stroke, but receive no specific therapy. Some will convert to abnormal velocities (TAMV ≥200 cm/s) with further increase in stroke risk. In 2003, our centre initiated universal TCD screening, targeting all children (aged 2-16 years) with SCA. TCD examinations were repeated at intervals based on initial results. To determine rates and risk factors for TCD conversion, we reviewed all examinations since 2003, excluding patients receiving hydroxycarbamide (hydroxyurea) or transfusions. Of the eligible population, 274 children (98%) were screened at a median age of 7.1 years (range 1.7-18.2). Fifty-four patients (20%) had conditional TAMV either on initial screening or a subsequent examination. The 18-month cumulative incidence of conversion from conditional to abnormal TAMV was 23%. Age, initial TAMV, laboratory values, blood pressure and oxygen saturation were not significantly associated with conversion. Our cohort provides systematic longitudinal evaluation of an unselected paediatric population universally screened and retested at regular intervals. Our data document a high conversion rate to abnormal velocities among untreated children with SCA. Therapy should be considered for the prevention of conversion to abnormal TCD velocities.

Original languageEnglish (US)
Pages (from-to)94-99
Number of pages6
JournalBritish Journal of Haematology
Volume142
Issue number1
DOIs
StatePublished - Jul 2008

Fingerprint

Sickle Cell Anemia
Natural History
Stroke
Hydroxyurea
Population
Pediatrics
Oxygen
Blood Pressure
Incidence
Therapeutics

Keywords

  • Sickle cell disease
  • Stroke
  • Transcranial Doppler

ASJC Scopus subject areas

  • Hematology

Cite this

The natural history of conditional transcranial Doppler flow velocities in children with sickle cell anaemia. / Hankins, Jane S.; Fortner, Gail L.; McCarville, M. Beth; Smeltzer, Matthew P.; Wang, Winfred C.; Li, Chin-Shang; Ware, Russell E.

In: British Journal of Haematology, Vol. 142, No. 1, 07.2008, p. 94-99.

Research output: Contribution to journalArticle

Hankins, Jane S. ; Fortner, Gail L. ; McCarville, M. Beth ; Smeltzer, Matthew P. ; Wang, Winfred C. ; Li, Chin-Shang ; Ware, Russell E. / The natural history of conditional transcranial Doppler flow velocities in children with sickle cell anaemia. In: British Journal of Haematology. 2008 ; Vol. 142, No. 1. pp. 94-99.
@article{ee258d1228834f9a855113f6eb9af126,
title = "The natural history of conditional transcranial Doppler flow velocities in children with sickle cell anaemia",
abstract = "Children with sickle cell anaemia (SCA) and conditional transcranial Doppler (TCD) [time-averaged mean velocity (TAMV) 170-199 cm/s] have increased risk of primary stroke, but receive no specific therapy. Some will convert to abnormal velocities (TAMV ≥200 cm/s) with further increase in stroke risk. In 2003, our centre initiated universal TCD screening, targeting all children (aged 2-16 years) with SCA. TCD examinations were repeated at intervals based on initial results. To determine rates and risk factors for TCD conversion, we reviewed all examinations since 2003, excluding patients receiving hydroxycarbamide (hydroxyurea) or transfusions. Of the eligible population, 274 children (98{\%}) were screened at a median age of 7.1 years (range 1.7-18.2). Fifty-four patients (20{\%}) had conditional TAMV either on initial screening or a subsequent examination. The 18-month cumulative incidence of conversion from conditional to abnormal TAMV was 23{\%}. Age, initial TAMV, laboratory values, blood pressure and oxygen saturation were not significantly associated with conversion. Our cohort provides systematic longitudinal evaluation of an unselected paediatric population universally screened and retested at regular intervals. Our data document a high conversion rate to abnormal velocities among untreated children with SCA. Therapy should be considered for the prevention of conversion to abnormal TCD velocities.",
keywords = "Sickle cell disease, Stroke, Transcranial Doppler",
author = "Hankins, {Jane S.} and Fortner, {Gail L.} and McCarville, {M. Beth} and Smeltzer, {Matthew P.} and Wang, {Winfred C.} and Chin-Shang Li and Ware, {Russell E.}",
year = "2008",
month = "7",
doi = "10.1111/j.1365-2141.2008.07167.x",
language = "English (US)",
volume = "142",
pages = "94--99",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - The natural history of conditional transcranial Doppler flow velocities in children with sickle cell anaemia

AU - Hankins, Jane S.

AU - Fortner, Gail L.

AU - McCarville, M. Beth

AU - Smeltzer, Matthew P.

AU - Wang, Winfred C.

AU - Li, Chin-Shang

AU - Ware, Russell E.

PY - 2008/7

Y1 - 2008/7

N2 - Children with sickle cell anaemia (SCA) and conditional transcranial Doppler (TCD) [time-averaged mean velocity (TAMV) 170-199 cm/s] have increased risk of primary stroke, but receive no specific therapy. Some will convert to abnormal velocities (TAMV ≥200 cm/s) with further increase in stroke risk. In 2003, our centre initiated universal TCD screening, targeting all children (aged 2-16 years) with SCA. TCD examinations were repeated at intervals based on initial results. To determine rates and risk factors for TCD conversion, we reviewed all examinations since 2003, excluding patients receiving hydroxycarbamide (hydroxyurea) or transfusions. Of the eligible population, 274 children (98%) were screened at a median age of 7.1 years (range 1.7-18.2). Fifty-four patients (20%) had conditional TAMV either on initial screening or a subsequent examination. The 18-month cumulative incidence of conversion from conditional to abnormal TAMV was 23%. Age, initial TAMV, laboratory values, blood pressure and oxygen saturation were not significantly associated with conversion. Our cohort provides systematic longitudinal evaluation of an unselected paediatric population universally screened and retested at regular intervals. Our data document a high conversion rate to abnormal velocities among untreated children with SCA. Therapy should be considered for the prevention of conversion to abnormal TCD velocities.

AB - Children with sickle cell anaemia (SCA) and conditional transcranial Doppler (TCD) [time-averaged mean velocity (TAMV) 170-199 cm/s] have increased risk of primary stroke, but receive no specific therapy. Some will convert to abnormal velocities (TAMV ≥200 cm/s) with further increase in stroke risk. In 2003, our centre initiated universal TCD screening, targeting all children (aged 2-16 years) with SCA. TCD examinations were repeated at intervals based on initial results. To determine rates and risk factors for TCD conversion, we reviewed all examinations since 2003, excluding patients receiving hydroxycarbamide (hydroxyurea) or transfusions. Of the eligible population, 274 children (98%) were screened at a median age of 7.1 years (range 1.7-18.2). Fifty-four patients (20%) had conditional TAMV either on initial screening or a subsequent examination. The 18-month cumulative incidence of conversion from conditional to abnormal TAMV was 23%. Age, initial TAMV, laboratory values, blood pressure and oxygen saturation were not significantly associated with conversion. Our cohort provides systematic longitudinal evaluation of an unselected paediatric population universally screened and retested at regular intervals. Our data document a high conversion rate to abnormal velocities among untreated children with SCA. Therapy should be considered for the prevention of conversion to abnormal TCD velocities.

KW - Sickle cell disease

KW - Stroke

KW - Transcranial Doppler

UR - http://www.scopus.com/inward/record.url?scp=44649195866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44649195866&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2008.07167.x

DO - 10.1111/j.1365-2141.2008.07167.x

M3 - Article

C2 - 18477038

AN - SCOPUS:44649195866

VL - 142

SP - 94

EP - 99

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 1

ER -